Cmpx stock forecast.

Back to CMPX Overview. *The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. It is possible that this date will be updated in the future, once ...

Cmpx stock forecast. Things To Know About Cmpx stock forecast.

Compass Therapeutics, Inc. Common Stock (CMPX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.The consensus price target of analysts on Wall Street is $2.50, which implies an increase of 83.2% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $2.50 and $2.50 respectively. As a result, VGZ is trading at a discount of -495.24% off the target high and -495.24% off the low.Future criteria checks 0/6. Compass Therapeutics is forecast to grow earnings and revenue by 21.6% and 76.7% per annum respectively while EPS is expected to grow by 25.3% per annum.Compass Therapeutics Inc. is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 34 means that 66% of …Planning a trip can be an exciting but challenging task. From booking accommodations to creating an itinerary, there are countless details to consider. One crucial aspect that should never be overlooked is checking the 7-day weather forecas...

Stock Price Forecast. The 6 analysts offering 12-month price forecasts for Compass Minerals International Inc have a median target of 43.50, with a high estimate of 82.00 and a low estimate of 36. ... The Compass Therapeutics, Inc. stock price gained 2.42% on the last trading day (Friday, 1st Dec 2023), rising from $1.65 to $1.69. During the last trading …

4 brokers have issued twelve-month target prices for Catalyst Pharmaceuticals' stock. Their CPRX share price targets range from $24.00 to $27.00. On average, they predict the company's stock price to reach $24.75 in the next twelve months. This suggests a possible upside of 67.0% from the stock's current price.

Compass Therapeutics. Compass Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is developing proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. Its pipeline product candidates are CTX-471/ CD137 agonist and CTX-8371.A convolutional neural network (CNN) is applied to forecast stock price changes in the Chinese stock market. We use 27 technical indicators and 5 original price series as benchmark models and ...Jun 15, 2023 · Learn more about Compass Therapeutics, Inc.'s (CMPX) dividend history, ex-dividend date, and yield. Zacks.com Our Research, Your Success Stock Price Forecast. The 6 analysts offering 12-month price forecasts for Compass Minerals International Inc have a median target of 43.50, with a high estimate of 82.00 and a low estimate of 36. ...Comprehensive selection of real-time charts, which plot movements in the forex, futures and stock markets, with quotes updated continuously throughout the trading day.

Compass Therapeutics, Inc. (CMPX) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 1.6500 -0.0700 (-4.07%) At close: 04:00PM EST 1.6500 0.00 (0.00%) After hours: 04:20PM EST...

Stock analysis for Compass Therapeutics Inc (CMPX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and …

Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...The Bridgebio Pharma Inc. stock price fell by -1.28% on the last day (Wednesday, 29th Nov 2023) from $28.84 to $28.47. During the last trading day the stock fluctuated 4.69% from a day low at $28.37 to a day high of $29.70. The price has been going up and down for this period, and there has been a -3.43% loss for the last 2 weeks.Find the latest Blue Water Biotech, Inc. (BWV) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest argenx SE (ARGX) stock quote, history, news and other vital information to help you with your stock trading and investing.CMPX Stock Forecast 2023. Compass Therapeutics boasts a robust drug pipeline, which explains why analysts are bullish on the stock. The Phase 2 and Phase 3 studies for cancer drug CTX-009 extend into H2 2023, at which time the company plans to initiate a Phase 1 study for its CTX-8371 drug also for cancer after filing an Investigational New Drug Application (IND) earlier in 2023.CMPX Overview Stock Screener Earnings Calendar Sectors Nasdaq | CMPX U.S.: Nasdaq Compass Therapeutics Inc. Watch NEW Set a price target alert After Hours Last …Compass Therapeutics Inc (CMPX) Reports Q3 2023 Financial Results and Corporate Developments. Get the latest Compass Therapeutics, Inc. (CMPX) stock news and headlines to help you in your trading ...

Milestone Pharmaceuticals (MIST) Stock Forecast, Price ...Compass Therapeutics Inc. (CMPX) stock is trading at $3.95 as of 12:48 PM on Tuesday, Jan 31, an increase of $0.10, or 2.6% from the previous closing price of $3.85. The stock has traded between $3.88 and $4.13 so far today. Volume today is less active than usual.Previous Close $3.68. Volume 32.29K. Average Volume (3M) 157.25K. Market Cap. $1.22B. Enterprise Value $963.30M. Total Cash (Recent Filing) $259.49M. Total Debt (Recent Filing) $921.00K. Price to Earnings (P/E) -5.0.All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange ...Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET.News Ideas Financials Technicals Forecast CMPX chart Today 2.59% 5 days 2.06% 1 month 3.66% 6 months −31.25% Year to date −61.10% 1 year −34.44% 5 years −76.71% All time −76.71% Key stats Market capitalization 252.37M USD Dividends yield (FY) — Price to earnings Ratio (TTM) — Basic EPS (TTM) −0.37 USD Net income −39.225M USD Revenue — Shares float

Complete Compass Therapeutics Inc. stock information by Barron's. View real-time CMPX stock price and news, along with industry-best analysis.

The stock has increased 17.9% in price over the past month and closed Friday’s trading session at $3.03. Each of the four Wall Street analysts that rated ELEV rated it Buy. The 12-month median price target of $11.50 indicates a 279.5% potential upside. The price targets range from a low of $11.00 to a high of $12.00.Track COMPASS Pathways (CMPS) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors The stock of Compass Therapeutics Inc (CMPX) has gone down by -4.07% for the week, with a -8.33% drop in the past month and a -29.18% drop in the past quarter. The volatility ratio for the week is 4.13%, and the volatility levels for the past 30 days are 7.49% for CMPX. The simple moving […]Compass Therapeutics, Inc. Common Stock (CMPX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. According to 42 stock analysts, the average 12-month stock price forecast for Amazon stock is $170.76, which predicts an increase of 16.14%. The lowest target is $116 and the highest is $230. On average, analysts rate Amazon stock as a strong buy.... Cmpx 2022, House of the rising sun shrewsbury, Predator alien face, Eye ... share price, Byo wedding venues philadelphia, Veterinary care near me, Tony ...Stock analysis for CompX International Inc (CIX:NYSEAmerican) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Nov 10, 2023 · Website. 2014. 26. Tom Schuetz. https://www.compasstherapeutics.com. Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company’s product candidates include CTX-009, a bispecific antibody that blocks Delta-like ligand 4 ... Find the latest Catalyst Pharmaceuticals, Inc. (CPRX) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term ...

Future criteria checks 0/6. Compass Therapeutics is forecast to grow earnings and revenue by 21.6% and 76.7% per annum respectively while EPS is expected to grow by 25.3% per annum.

The ALX Oncology Holdings Inc. stock price fell by -4.02% on the last day (Friday, 24th Nov 2023) from $9.21 to $8.84. During the last trading day the stock fluctuated 10.18% from a day low at $8.79 to a day high of $9.69. The price has risen in 6 of the last 10 days and is up by 12.76% over the past 2 weeks.

Find the latest Catalyst Pharmaceuticals, Inc. (CPRX) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term ...Stock analysis for CompX International Inc (CIX:NYSEAmerican) including stock price, stock chart, company news, key statistics, fundamentals and company profile.What is the difference between Tesla's targeted high price and its latest price? ... Stock comparison. Financial metrics over time. Search other exchanges. News ...Website. 2014. 26. Tom Schuetz. https://www.compasstherapeutics.com. Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company’s product candidates include CTX-009, a bispecific antibody that blocks Delta-like ligand 4 ...COMPX REPORTS THIRD QUARTER 2023 RESULTS. Dallas, Texas, Nov. 01, 2023 (GLOBE NEWSWIRE) -- CompX International Inc. (NYSE American: CIX) announced today sales of $40.3 million for the third quarter of 2023 compared to $42.9 million in the sam... 24 days ago - GlobeNewsWire.Compx International Inc: A High-Performing Stock with a GF Score of 93. GF Score analysis. Find the latest CompX International Inc. (CIX) stock quote, history, news and other vital information to ...The Mirum Pharmaceuticals, Inc. stock price fell by -2.22% on the last day (Tuesday, 28th Nov 2023) from $32.04 to $31.33. During the last trading day the stock fluctuated 4.28% from a day low at $30.75 to a day high of $32.06. The price has fallen in 6 of the last 10 days but is still up by 2.76% over the past 2 weeks.Compass Therapeutics, Inc. Common Stock (CMPX) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.Compass Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CMPX updated stock price target summary.

This brings the total capital commitment to the Fund to $1.8 billion. Find the latest Power Corporation of Canada (POW.TO) stock quote, history, news and other vital information to help you with your stock trading and investing.Track Cidara Therapeutics Inc (CDTX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsFeb 3, 2023 · View NASDAQ COMPOSITE COMPX investment & stock information. Get the latest NASDAQ COMPOSITE COMPX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Instagram:https://instagram. stock market labwhat is the cola for 2024leons furnitureon top movers The projected low price target is $8.00 while the price target rests at a high of $11.00. In that case, then, we find that the current price level is -618.95% off the targeted high while a plunge would see the stock gain -422.88% from current levels. Compass Therapeutics Inc (CMPX) estimates and forecastsFCEL Stock 12 Months Forecast. Based on 6 Wall Street analysts offering 12 month price targets for Fuelcell Energy in the last 3 months. The average price target is $1.65 with a high forecast of $2.00 and a low forecast of $1.00. The average price target represents a 35.25% change from the last price of $1.22. liquid battery stockshow to invest dollar10 Feb 3, 2023 · View NASDAQ COMPOSITE COMPX investment & stock information. Get the latest NASDAQ COMPOSITE COMPX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. The average TRACON Pharmaceuticals stock prediction of $12.40 implies an upside potential of 392.1% to current levels for this stock.Compass Therapeutics (NASDAQ: CMPX)Compass Therapeutics ... can you buy options after hours on robinhood Website. 2014. 26. Tom Schuetz. https://www.compasstherapeutics.com. Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company’s product candidates include CTX-009, a bispecific antibody that blocks Delta …Safe & Green Development Corp. $1.95. -0.70. -26.42%. COMP | A complete NASDAQ Composite Index index overview by MarketWatch. View stock market news, stock market data and trading information.The average Mind Medicine stock price prediction forecasts a potential upside of 810.6% from the current MNMD share price of $3.02. What is MNMD's forecast return on equity (ROE) for 2023-2026? (NASDAQ: MNMD) forecast ROE is N/A, which is considered weak.